Best Practice & Research Clinical Rheumatology
Volume 23, Issue 3 , Pages 339-353 , June 2009

Chronic periaortitis: a fibro-inflammatory disorder

References 

  1. Mitchinson MJ. The pathology of idiopathic retroperitoneal fibrosis. J Clin Pathol. 1970;23:681–689
  2. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367:241–251
  3. Parums DV. The spectrum of chronic periaortitis. Histopathology. 1990;16:423–431
  4. Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery. 1977;81:250–257
  5. Hughes D, Buckley PJ. Idiopathic retroperitoneal fibrosis is a macrophage-rich process. Implications for its pathogenesis and treatment. Am J Surg Pathol. 1993;17:482–490
  6. Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med. 2003;114:454–462
  7. Serra RM, Engle JE, Jones RE, et al. Perianeurysmal retroperitoneal fibrosis. An unusual cause of renal failure. Am J Med. 1980;68:149–153
  8. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–1589
  9. Greco P, Vaglio A, Corradi D, et al. Tuberculosis as a trigger of retroperitoneal fibrosis. Clin Infect Dis. 2005;41:72–75
  10. Salvarani C, Pipitone N, Versari A, et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum. 2005;53:298–303
  11. Pipitone N, Ghinoi A, Versari A, et al. Images in cardiovascular medicine. Chronic periaortitis. Circulation. 2008;118:1214–1216
  12. Okada H, Takahira S, Sugahara S, et al. Retroperitoneal fibrosis and systemic lupus erythematosus. Nephrol Dial Transplant. 1999;14:1300–1302
  13. Tsai TC, Chang PY, Chen BF, et al. Retroperitoneal fibrosis and juvenile rheumatoid arthritis. Pediatr Nephrol. 1996;10:208–209
  14. Vaglio A, Palmisano A, Corradi D, et al. Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am. 2007;33:803–817vi–i
  15. Vaglio A, Palmisano A, Ferretti S, et al. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature. Rheumatology (Oxford). 2008;47:315–318
  16. de RS, Serratrice J, Granel B, et al. Periaortitis heralding Wegener's granulomatosis. J Rheumatol. 2002;29:392–394
  17. Hautekeete ML, Babany G, Marcellin P, et al. Retroperitoneal fibrosis after surgery for aortic aneurysm in a patient with periarteritis nodosa: successful treatment with corticosteroids. J Intern Med. 1990;228:533–536
  18. Ohara H, Nakazawa T, Ando T, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol. 2007;42(Suppl. 18):15–21
  19. Vaglio A, Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol. 2005;17:34–40
  20. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948–3955
  21. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613–625
  22. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–1404
  23. Kamisawa T. Is it time to reconsider autoimmune pancreatitis?. J Gastroenterol. 2006;41:1240–1241
  24. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–738
  25. Matsumoto Y, Kasashima S, Kawashima A, et al. A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum Pathol. 2008;39:975–980
  26. Ito H, Kaizaki Y, Noda Y, et al. IgG4-related inflammatory abdominal aortic aneurysm associated with autoimmune pancreatitis. Pathol Int. 2008;58:421–426
  27. Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2008;32:197–204
  28. Sakata N, Tashiro T, Uesugi N, et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:553–559
  29. Comings DE, Skubi KB, Van Eyes J, et al. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med. 1967;66:884–892
  30. Dehner LP, Coffin CM. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol. 1998;15:161–173
  31. Bahler C, Hammoud Z, Sundaram C. Mediastinal fibrosis in a patient with idiopathic retroperitoneal fibrosis. Interact Cardiovasc Thorac Surg. 2008;7:336–338
  32. Corradi D, Maestri R, Palmisano A, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007;72:742–753
  33. Pasquinelli G, Preda P, Gargiulo M, et al. An immunohistochemical study of inflammatory abdominal aortic aneurysms. J Submicrosc Cytol Pathol. 1993;25:103–112
  34. Gornik HL, Creager MA. Aortitis. Circulation. 2008;117:3039–3051
  35. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–245
  36. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995;122:502–507
  37. Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522–3531
  38. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–929
  39. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–1134
  40. Haynes BF, Kaiser-Kupfer MI, Mason P, et al. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore). 1980;59:426–441
  41. Foote EA, Postier RG, Greenfield RA, et al. Infectious aortitis. Curr Treat Options Cardiovasc Med. 2005;7:89–97
  42. Virmani R, Burke AP, Farb A. Sudden cardiac death. Cardiovasc Pathol. 2001;10:275–282
  43. Muller BT, Wegener OR, Grabitz K, et al. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg. 2001;33:106–113
  44. Miller DV, Isotalo PA, Weyand CM, et al. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006;30:1150–1158
  45. Kerr LD, Chang YJ, Spiera H, et al. Occult active giant cell aortitis necessitating surgical repair. J Thorac Cardiovasc Surg. 2000;120:813–815
  46. Rojo-Leyva F, Ratliff NB, Cosgrove DM, et al. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43:901–907
  47. Uibu T, Oksa P, Auvinen A, et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004;363:1422–1426
  48. Rasmussen TE, Hallett JW. Inflammatory aortic aneurysms. A clinical review with new perspectives in pathogenesis. Ann Surg. 1997;225:155–164
  49. Yusuf K, Murat B, Unal A, et al. Inflammatory abdominal aortic aneurysm: predictors of long-term outcome in a case-control study. Surgery. 2007;141:83–89
  50. von Fritschen U, Malzfeld E, Clasen A, et al. Inflammatory abdominal aortic aneurysm: A postoperative course of retroperitoneal fibrosis. J Vasc Surg. 1999;30:1090–1098
  51. Jois RN, Gaffney K, Marshall T, et al. Chronic periaortitis. Rheumatology (Oxford). 2004;43:1441–1446
  52. Baker LR, Mallinson WJ, Gregory MC, et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol. 1987;60:497–503
  53. Miller OF, Smith LJ, Ferrara EX, et al. Presentation of idiopathic retroperitoneal fibrosis in the pediatric population. J Pediatr Surg. 2003;38:1685–1688
  54. Gilkeson GS, Allen NB. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am. 1996;22:23–38
  55. Doolin EJ, Goldstein H, Kessler B, et al. Familial retroperitoneal fibrosis. J Pediatr Surg. 1987;22:1092–1094
  56. Duffy PG, Johnston SR, Donaldson RA. Idiopathic retroperitoneal fibrosis in twins. J Urol. 1984;131:746
  57. Rasmussen TE, Hallett JW, Metzger RL, et al. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J Vasc Surg. 1997;25:356–364
  58. Martorana D, Vaglio A, Greco P, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. 2006;55:126–130
  59. Hellmann DB, Grand DJ, Freischlag JA. Inflammatory abdominal aortic aneurysm. JAMA. 2007;297:395–400
  60. Kardar AH, Kattan S, Lindstedt E, et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol. 2002;168:550–555
  61. van Bommel EF, Siemes C, Hak LE, et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis. 2007;49:615–625
  62. Marcolongo R, Tavolini IM, Laveder F, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med. 2004;116:194–197
  63. Vaglio A, Greco P, Versari A, et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent ‘scar’? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol. 2005;23:231–234
  64. Vaglio A, Manenti L, Allegri L, et al. ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis?. J Intern Med. 2002;251:268–271
  65. Ghinoi A, Pipitone N, Boiardi L, et al. Primary Sjogren's syndrome associated with chronic periaortitis. Rheumatology (Oxford). 2007;46:719–720
  66. Armigliato M, Paolini R, Bianchini E, et al. Hashimoto's thyroiditis and Graves' disease associated with retroperitoneal fibrosis. Thyroid. 2002;12:829–831
  67. Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med. 1990;114:383–387
  68. Parums DV, Chadwick DR, Mitchinson MJ. The localisation of immunoglobulin in chronic periaortitis. Atherosclerosis. 1986;61:117–123
  69. Ramshaw AL, Parums DV. The distribution of adhesion molecules in chronic periaortitis. Histopathology. 1994;24:23–32
  70. Ramshaw AL, Roskell DE, Parums DV. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol. 1994;47:721–727
  71. Breems DA, Haye H, van der Meulen J. The role of advanced atherosclerosis in idiopathic retroperitoneal fibrosis. Analysis of nine cases. Neth J Med. 2000;56:38–44
  72. Vanoli M, Daina E, Salvarani C, et al. Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum. 2005;53:100–107
  73. Vaglio A, Greco P, Corradi D, et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev. 2006;5:458–464
  74. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538–1546
  75. Tanaka S, Komori K, Okadome K, et al. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg. 1994;20:235–243
  76. Tang T, Boyle JR, Dixon AK, et al. Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2005;29:353–362
  77. Dei Tos A. Atypical lipomatous tumor/well differentiated liposarcoma. World Health Organisation Classification of tumours Pathology and Genetics of Tumours of Soft Tissue and Bone 2002: 35–37.
  78. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996;75:157–169
  79. Kottra JJ, Dunnick NR. Retroperitoneal fibrosis. Radiol Clin North Am. 1996;34:1259–1275
  80. Galan A, Cowper SE, Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol. 2006;18:614–617
  81. Canyigit M, Peynircioglu B, Hazirolan T, et al. Imaging characteristics of Takayasu arteritis. Cardiovasc Intervent Radiol. 2007;30:711–718
  82. Blockmans D, Van Moer E, Dehem J, et al. Positron emission tomography can reveal abdominal periaortitis. Clin Nucl Med. 2002;27:211–212
  83. Vaglio A, Versari A, Fraternali A, et al. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum. 2005;53:122–125
  84. Wenger M, Baltaci M, Klein-Weigel P, et al. 18F-FDG-positron emission tomography for diagnosis of large vessel arteritis in Behcet's disease. Adv Exp Med Biol. 2003;528:435–436
  85. Wenger M, Calamia KT, Salvarani C, et al. Do we need 18F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel arteritis?. Clin Exp Rheumatol. 2003;21:s1–2
  86. van Bommel EF, Siemes C, van der Veer SJ, et al. Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study. J Intern Med. 2007;262:224–234
  87. Arrive L, Hricak H, Tavares NJ, et al. Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging. Radiology. 1989;172:139–143
  88. Pickhardt PJ, Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics. 2005;25:719–730
  89. Vaglio A, Corradi D, Maestri R, et al. Pericarditis heralding Erdheim–Chester disease. Circulation. 2008;118:e511–e512
  90. Jois RN, Kerrigan N, Scott DG. Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis. Rheumatology (Oxford). 2007;46:717–718
  91. Scheel PJ, Piccini J, Rahman MH, et al. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol. 2007;178:140–143discussion 143–144
  92. Moroni G, Gallelli B, Banfi G, et al. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant. 2006;21:2485–2490
  93. van Bommel EF, Hendriksz TR, Huiskes AW, et al. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006;144:101–106
  94. Srinivasan AK, Richstone L, Permpongkosol S, et al. Comparison of laparoscopic with open approach for ureterolysis in patients with retroperitoneal fibrosis. J Urol. 2008;179:1875–1878
  95. Fry AC, Singh S, Gunda SS, et al. Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract. 2008;108:213–220

PII: S1521-6942(08)00152-6

doi: 10.1016/j.berh.2008.12.002

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 3 , Pages 339-353 , June 2009

Article Tools

* Image Usage & Resolution